AldexChem

AldexChem is a solution and platform provider for the Chemical and Life Science industries. Our mission is to support the development of new therapies that will improve the lives of millions of people around the world. AldexChem developed a novel hydrosilylation reaction filing its primary IP as Silbored™, facilitating the reduction of a wide range of esters to aldehydes which are difficult, critical or even impossible to convert with the standard toolbox of chemical synthesis. We are dedicated to providing robust and scalable tools for the chemical industries and developing building blocks for homologation reactions, which would be difficult to access with the standard toolbox of chemical synthesis. SilBoRed™ technology opened up a novel chemical space, allowing multiple industrial applications. In this new chemical space, LipexSil™ gives access to a novel lipid family, filing AldexChem’s secondary IP. A unique solution for one of the most pressing bottlenecks of the pharma industry – delivery of RNA drugs and vaccines. LipexSil™ develops and supplies ionizable lipids for the pharma industry which can be used in the preparation of LNPs for delivery of biologically active agents, in particular polynucleotides into cells. At LipexSil™, we believe that every innovative and groundbreaking discovery should be within reach, and our goal is to make that a reality by continuously advancing and perfecting our technology. At AldexChem, our vision is to revolutionize how the pharmaceutical and chemical industries approach the production and delivery of life-saving drugs and treatments. We strive to solve the pressing problems faced by the pharma industry, such as the efficient delivery of biologically active agents, by providing groundbreaking technology in the form of SilBoRed™ and LipexSil™. Our vision is to inspire change in the scientific community by pushing the boundaries of what is possible in chemical synthesis.